The purpose of this study is to better understand everything about nonalcoholic fatty live disease (NAFLD) that is possible.
Detailed description of study
The purpose of this study is to:
-To continue to investigate the etiology, pathogenesis, natural history, diagnosis, treatment, and prevention of nonalcoholic fatty liver disease (NAFLD) -To provide a resource for clinical trials and ancillary studies of the pathogenesis, natural history, diagnosis or diagnostic biomarker development and treatment of NAFLD, NASH, or NASH-related cirrhosis -To continue the development of histopathological methods for diagnosis and assessment of NAFLD, NASH, and NASH-related cirrhosis -To maintain and expand the centralized histopathological NAFLD repository and reading center -To develop imaging methods for non-invasive diagnosis and assessment of NAFLD, NASH, and NASH-related cirrhosis and to develop a NAFLD digital imaging repository and analysis center -To add to and expand the specimen bank comprising liver tissue, serum, plasma, and DNA obtained from participants with biopsy confirmed NAFLD
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Inclusion Criteria Have had a recent liver biopsy Exclusion Criteria Diagnosed with alcoholic liver disease Evidence of chronic hepatitis B or C Diagnosed with HIV Active drug use or dependence
Additional Information:
Participants will be paid for their participation.
Updated on
01 Aug 2024.
Study ID: 1011004057
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
